Table 2. Affinity Constants (Ka) of the Compounds for Binding to MTs and Effect of Single-Point Ligand Changes on the Binding Affinity of the Ligands for MTs.
Ka (107 M–1) | |||||||||
---|---|---|---|---|---|---|---|---|---|
ligand | 26 °C | 27 °C | 30 °C | 32 °C | 35 °C | 37 °C | 40 °C | 42 °C | ΔG 35 °C (kJ mol–1) |
paclitaxel3 | 2.64 ± 0.2 | 2.19 ± 0.05 | 1.83 ± 0.1 | 1.81 ± 0.2 | 1.43 ± 0.2 | 1.07 ± 0.1 | 0.96 ± 0.1 | 0.94 ± 0.2 | –42.2 ± 0.4 |
docetaxel3 | 6.95 ± 0.4 | 6.57 ± 0.5 | 5.42 ± 0.4 | 4.89 ± 0.4 | 3.93 ± 0.3 | 3.09 ± 0.2 | 2.89 ± 0.2 | 2.38 ± 0.1 | –44.8 ± 0.2 |
dictyostatin3 | 35.5 ± 7 | 32.0 ± 5.5 | 24.8 ± 3 | 23.1 ± 3 | 19.2 ± 2.5 | 16.8 ± 2 | 14.1 ± 2 | 14.2 ± 2 | –48.8 ± 0.4 |
2 | 0.0051 ± 0.003 | 0.0050 ± 0.003 | 0.0047 ± 0.003 | 0.0048 ± 0.0035 | 0.0041 ± 0.0026 | 0.0035 ± 0.002 | 0.0037 ± 0.001 | 0.0035 ± 0.002 | –27.2 ± 1.2 |
discodermolide3 | 872 ± 82 | 837 ± 77 | 958 ± 134 | 704 ± 95 | 555 ± 111 | 526 ± 72 | 547 ± 60 | 321 ± 73 | –57.4 ± 0.5 |
5 | 2.4 ± 1.2 | 2.5 ± 1.1 | 2.6 ± 1.2 | 2.4 ± 1.2 | 2.2 ± 0.4 | 2.2 ± 0.45 | 1.9 ± 0.25 | 1.87 ± 0.4 | –43.3 ± 0.4 |
7 | 0.06 ± 0.02 | 0.05 ± 0.02 | 0.06 ± 0.01 | 0.07 ± 0.01 | 0.06 ± 0.01 | 0.06 ± 0.02 | 0.04 ± 0.01 | 0.04 ± 0.2 | –34.4 ± 0.4 |
8 | 2.1 ± 0.4 | 1.9 ± 0.5 | 1.7 ± 0.3 | 1.7 ± 0.4 | 1.6 ± 0.2 | 1.4 ± 0.2 | 1.4 ± 0.2 | 1.2 ± 0.3 | –42.5 ± 0.3 |
10 | 0.62 ± 0.3 | 0.66 ± 0.3 | 0.57 ± 0.2 | 0.62 ± 0.25 | 0.54 ± 0.2 | 0.51 ± 0.2 | 0.49 ± 0.2 | 0.45 ± 0.2 | –39.7 ± 0.8 |
11 | 0.33 ± 0.05 | 0.36 ± 0.1 | 0.29 ± 0.09 | 0.27 ± 0.07 | 0.28 ± 0.05 | 0.25 ± 0.01 | 0.3 ± 0.02 | 0.23 ± 0.02 | –38.0 ± 0.4 |
13 | 1.13 ± 0.3 | 1.12 ± 0.3 | 0.98 ± 0.2 | 0.95 ± 0.15 | 0.73 ± 0.1 | 0.71 ± 0.1 | 0.56 ± 0.1 | 0.58 ± 0.08 | –40.4 ± 0.3 |
14 | 0.07 ± 0.03 | 0.055 ± 0.02 | 0.043 ± 0.01 | 0.04 ± 0.006 | 0.033 ± 0.005 | 0.025 ± 0.004 | 0.029 ± 0.004 | 0.028 ± 0.01 | –32.5 ± 0.4 |
15 | 0.29 ± 0.1 | 0.29 ± 0.1 | 0.3 ± 0.1 | 0.33 ± 0.07 | 0.32 ± 0.1 | 0.33 ± 0.2 | 0.4 ± 0.2 | 0.28 ± 0.05 | –38.3 ± 0.7 |
16 | 0.32 ± 0.2 | 0.4 ± 0.2 | 0.4 ± 0.1 | 0.4 ± 0.1 | 0.35 ± 0.08 | 0.35 ± 0.1 | 0.3 ± 0.1 | 0.25 ± 0.07 | –38.6 ± 0.5 |
Ka (107 M–1) |
|||||
---|---|---|---|---|---|
ligand | 25 °C | 30 °C | 35 °C | 40 °C | ΔG 35 °C (kJ mol–1) |
4 | 119.3 ± 3 | 68.5 ± 8 | 53.8 ± 4.8 | 34 ± 1.3 | 51.5 ± 0.2 |
6 | 88.1 ± 14 | 55 ± 3 | 32.6 ± 3.4 | 26.4 ± 2.5 | 50.2 ± 0.3 |
9 | 229.7 ± 22 | 175 ± 16.5 | 113.8 ± 3.25 | 63.4 ± 2 | 53.4 ± 0.1 |
12 | 106.4 ± 32 | 75.1 ± 4 | 65.2 ± 2.6 | 32.2 ± 1.5 | 51.9 ± 0.1 |
change | description | ΔΔG 35 °C (kJ mol–1) |
---|---|---|
1 → 4 | removal of C6 methyl | –2.7 |
1 → 5 | reduction of C10=C11 double bond | +5.5 |
12 → 13 | +11.5 | |
1 → 6 | reduction of C2=C3 double bond | –1.4 |
1 → 10 | removal of C16 methyl | +9.1 |
11 → 7 | +3.6 | |
1 → 11 | epimerization of C9 hydroxyl | +10.8 |
10 → 7 | +5.3 | |
15 → 16 | –0.3 | |
6 → 8 | reduction of C4=C5 double bond | +6.1 |
1 → 9 | methylation of C9 hydroxyl | –4.6 |
12 → 15 | reduction of C4=C5 double bond and hydroxylation at C5 | +13.6 |
12 → 14 | introduction of docetaxel side chain at C7 | +19.4 |
1 → 14 | esterification of C7 hydroxyl | +9.7 |